BIIB vs IIIV · P/E 21, rev $9.89B vs P/E 179, rev $54.9M
Biogen Inc (BIIB) versus i3 Verticals Inc (IIIV) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
i3 Verticals Inc (IIIV) is a software - infrastructure company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported IIIV revenue for 2025-09-30 was $54.9M. Net income was $26.5M. Revenue was up 5.8% from 2025-06-30 to 2025-09-30. IIIV currently screens at market cap $549.7M and trailing P/E 178.9.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. IIIV currently screens at market cap $549.7M and trailing P/E 178.9.
Not investment advice. Open the BIIB and IIIV stock pages for the full models.
Not investment advice.